Production (Stage)
CorMedix Inc.
CRMD
$11.22
-$0.49-4.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.18M | -17.93M | -46.15M | -53.12M | -50.24M |
| Total Depreciation and Amortization | 449.90K | 309.80K | 194.80K | 135.20K | 75.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.48M | 6.41M | 6.30M | 6.07M | 5.86M |
| Change in Net Operating Assets | -38.68M | -39.41M | -16.09M | -3.88M | -1.02M |
| Cash from Operations | -13.57M | -50.61M | -55.75M | -50.79M | -45.33M |
| Capital Expenditure | -64.70K | -115.80K | -401.80K | -402.20K | -373.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.16M | 21.35M | 22.53M | 15.63M | 6.94M |
| Cash from Investing | 12.09M | 21.23M | 22.13M | 15.22M | 6.57M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.72M | 26.61M | 15.74M | 44.56M | 48.91M |
| Repurchase of Common Stock | -1.21M | -289.60K | -236.60K | -236.60K | -295.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.51M | 26.32M | 15.50M | 44.33M | 48.62M |
| Foreign Exchange rate Adjustments | -700.00 | -1.70K | 1.90K | -600.00 | -300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.03M | -3.07M | -18.11M | 8.76M | 9.86M |